Home
>
National Drug Code (NDC)
>
Trental
Trental - 0039-0078-10 - (pentoxifylline)
Drug Information of Trental
| Product NDC: | 0039-0078 |
| Proprietary Name: | Trental |
| Non Proprietary Name: | pentoxifylline |
| Active Ingredient(s): | 400 mg/1 & nbsp; pentoxifylline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Trental
| Product NDC: | 0039-0078 |
| Labeler Name: | Sanofi-Aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018631 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19840830 |
Package Information of Trental
| Package NDC: | 0039-0078-10 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0039-0078-10) |
NDC Information of Trental
| NDC Code | 0039-0078-10 |
| Proprietary Name | Trental |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0039-0078-10) |
| Product NDC | 0039-0078 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pentoxifylline |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19840830 |
| Marketing Category Name | NDA |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Substance Name | PENTOXIFYLLINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
